According to a report by TASS, the President of Japan Tobacco (JT), Masamichi Terabatake, stated in an interview with Kyodo News that JT intends to continue its tobacco business operations in the Russian market.
Teruhito Terahata emphasizes that JT still has a choice in whether or not to sell its operations in Russia. However, they desire to maintain their presence in the Russian market for as long as possible.
In addition, Masamichi Terahata mentioned that the company intends to retain its employees in Ukraine and has already begun partially restoring production.
In Russia, JT owns four factories with a total workforce of 4,000 employees, including production and management personnel.
On March 10, 2022, Japan Tobacco Russia subsidiary announced the suspension of new investments and additional marketing activities in Russia.
Last year, the company temporarily suspended operations in the central Ukrainian city of Kremenchyhy.
The products of Japan Tobacco are currently sold in 130 countries worldwide. It is reported that the company entered the cigarette market in Russia in 1992, and over the past 20 years, its investments in Russia have exceeded 4.6 billion US dollars.
References:
[1] Japan Tobacco plans to maintain its business in Russia
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
